Bull Street Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$708K Hold
14,770
0.32% 66
2026
Q1
$543K Hold
14,770
0.27% 72
2025
Q4
$751K Hold
14,770
0.35% 61
2025
Q3
$820K Hold
14,770
0.38% 60
2025
Q2
$1.02M Hold
14,770
0.49% 56
2025
Q1
$1.03M Hold
14,770
0.49% 57
2024
Q4
$1.27M Hold
14,770
0.61% 52
2024
Q3
$1.76M Sell
14,770
-240
-2% -$32K 0.82% 39
2024
Q2
$2.14M Sell
15,010
-220
-1% -$29.2K 1.03% 34
2024
Q1
$1.96M Sell
15,230
-350
-2% -$41.7K 0.94% 35
2023
Q4
$1.61M Sell
15,580
-150
-1% -$14.8K 0.82% 38
2023
Q3
$1.43M Sell
15,730
-100
-0.6% -$8.81K 0.76% 41
2023
Q2
$1.28M Sell
15,830
-1,830
-10% -$149K 0.66% 51
2023
Q1
$1.41M Sell
17,660
-80
-0.5% -$5.67K 0.73% 45
2022
Q4
$1.2M Hold
17,740
0.62% 50
2022
Q3
$884K Hold
17,740
0.5% 59
2022
Q2
$988K Hold
17,740
0.53% 58
2022
Q1
$985K Hold
17,740
0.48% 62
2021
Q4
$993K Sell
17,740
-200
-1% -$10.8K 0.47% 58
2021
Q3
$861K Sell
17,940
-200
-1% -$9.67K 0.44% 60
2021
Q2
$760K Hold
18,140
0.41% 61
2021
Q1
$611K Hold
18,140
0.34% 65
2020
Q4
$634K Hold
18,140
0.38% 62
2020
Q3
$630K Hold
18,140
0.43% 58
2020
Q2
$594K Sell
18,140
-250
-1% -$7.98K 0.46% 57
2020
Q1
$554K Sell
18,390
-280
-1% -$8.34K 0.5% 57
2019
Q4
$540K Sell
18,670
-350
-2% -$9.69K 0.47% 59
2019
Q3
$492K Buy
+19,020
New +$481K 0.46% 60

Other funds holding NVO

Bull Street Advisors's NVO Position: Q2 2026 in Review

Bull Street Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 14,770 shares worth $708K. The position accounts for 0.32% of the portfolio, ranked #66.

Bull Street Advisors first reported a position in NVO in Q3 2019 and has held it in 28 quarters since. The position peaked at $2.14M in Q2 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bull Street Advisors held 14,770 shares of Novo Nordisk worth $708K as of Q2 2026.
  • Bull Street Advisors left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.32% of Bull Street Advisors's portfolio in Q2 2026, its #66 holding.
  • Bull Street Advisors first reported a position in Novo Nordisk in Q3 2019 and has held it in 28 quarters since.
  • Bull Street Advisors's Novo Nordisk position peaked at $2.14M in Q2 2024.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bull Street Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.